Prevention of cardiovascular disease

[1]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[2]  R. Collins,et al.  Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. , 1989, Circulation.

[3]  R. Doll,et al.  An overview of the British and American aspirin studies. , 1988, The New England journal of medicine.

[4]  C. Hennekens,et al.  The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension. , 1988, American journal of epidemiology.

[5]  United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results , 1988, British medical journal.

[6]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[7]  J. Buring,et al.  Epidemiology in Medicine , 1987 .

[8]  S Moncada,et al.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. , 1979, The New England journal of medicine.

[9]  B Rosner,et al.  A Case-Control Study of Regular Aspirin Use and Coronary Deaths , 1978, Circulation.

[10]  E. C. Hammond,et al.  Aspirin and coronary heart disease: findings of a prospective study. , 1975, British medical journal.

[11]  C. Hennekens.  Aspirin in the Secondary Prevention of Cardiovascular Disease , 1992 .

[12]  Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.

[13]  Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study. , 1988, The New England journal of medicine.

[14]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[15]  R. Collins,et al.  CHOLESTEROL-LOWERING TRIAL RESULTS IN THEIR EPIDEMIOLOGIC CONTEXT , 1985 .